Department of Defense PTSD Adaptive Platform Trial - Intervention D - SLS-002
Part of paid clinical trials in Miami, Florida.
- Sponsor
- Global Coalition for Adaptive Research
- Study ID
- NCT06816433
- Phase
- PHASE2
- Status
- Suspended
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- Intervention D SLS-002 — DRUGSLS-002 will be administered via intranasal administration (one spray per nostril, per device) at 78 mg two times per week for the first eight weeks and then once a week for the last four weeks.
- Intervention D Placebo — DRUGA matching placebo will be administered via intranasal administration (one spray per nostril, per device) two times per week for the first eight weeks and then once a week for the last four weeks.
Study Details
This is a Phase 2 randomized, double-blinded, placebo-controlled study that will evaluate multiple potential pharmacotherapeutic interventions for Post Traumatic Stress Disorder (PTSD) utilizing an adaptive platform trial (APT) design. Intervention D - SLS-002 will assess the safety and efficacy of SLS-002 in participants with PTSD. Please see NCT05422612 for information on the S-21-02 Master Protocol.
Key Dates
- First listed
- Feb 10, 2025
- Start date
- May 31, 2028
- Status verified
- May 2026
- Primary completion
- May 31, 2029
- Completion
- Jul 31, 2029
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Intervention D: SLS-002
- Placebo Comparator: Intervention D: Placebo
Primary Outcome Measure
Absolute change in the Clinician-Administered PTSD Scale-5-Revised (CAPS-5-R) Past Month total score at Week 12 (Final/Early termination Visit). [ Time Frame: 12 Weeks ]
Locations (9)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Homestead Associates in Research, Inc. | Miami | Florida | 33032 | - |
| Advanced Discovery Research | Atlanta | Georgia | 30318 | - |
| Tripler Army Medical Center (TAMC) | Tripler AMC | Hawaii | 96859 | - |
| Cincinnati Veteran's Affairs Medical Center | Fort Thomas | Kentucky | 41075 | - |
| Walter Reed National Military Medical Center (WRNMC) | Bethesda | Maryland | 20889-5632 | - |
| Upstate Clinical Research Associates, LLC | Williamsville | New York | 14221 | - |
| Wilford Hall Ambulatory Surgical Center (WHASC) | San Antonio | Texas | 78236 | - |
| Alexander T. Augusta Military Medical Center (ATAMMC): | Fort Belvoir | Virginia | 22060-5285 | - |
| Madigan Army Medical Center | Joint Base Lewis McChord | Washington | 98433 | - |
Find similar trials in Miami, FL
Nationwide
By condition
By specialty
By research site
Homestead Associates in Research, Inc.· Miami, FLAdvanced Discovery Research· Atlanta, GATripler Army Medical Center (TAMC)· Tripler AMC, HICincinnati Veteran's Affairs Medical Center· Fort Thomas, KYWalter Reed National Military Medical Center (WRNMC)· Bethesda, MDUpstate Clinical Research Associates, LLC· Williamsville, NY
Related Studies
- Non-invasive Nerve Stimulation for PTSD and SleepRecruiting · University of Florida · Gainesville, Florida
- Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSDPHASE2 · Recruiting · NYU Langone Health · New York, New York
- Neuromodulation and Neurorehabilitation for mTBIRecruiting · Northwestern University · Chicago, Illinois
- Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSDRecruiting · The University of Texas at Dallas · Tallahassee, Florida